View Information Collection Request (ICR) Package

OMB Control No: 0935-0251	ICR Reference No: 202004-0935-003
Status: Historical Active	Previous ICR Reference No:
Agency/Subagency: HHS/AHRQ	Agency Tracking No:
Title: Evaluating the Implementation of Products to Help Learning Health Systems Use Findings from AHRQ Evidence Reports
Type of Information Collection: New collection (Request for a new OMB Control Number)	Common Form ICR: No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 07/21/2020
	Date Received in OIRA: 04/16/2020
Terms of Clearance: AHRQ will ensure that respondents receive the information on the PRA burden statement, including where to address comments on the estimate of the burden and suggestions for reducing burden.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	07/31/2023	36 Months From Approved
Responses	308	0	0
Time Burden (Hours)	216	0	0
Cost Burden (Dollars)	0	0	0

Abstract: AHRQ’s Evidence-based Practice Center (EPC) Program has 20 years of experience in synthesizing research to inform evidence-based health care practice, delivery, policies, and research. The AHRQ EPC program is committed to partnering with organizations to make sure its evidence reports can be used in practice. Historically, most of its evidence reports have been used by clinical professional organizations to support the development of clinical practice guidelines or Federal agencies to inform their program planning and research priorities. To improve uptake and relevance of the AHRQ EPC’s evidence reports, specifically for health systems, AHRQ has funded the American Institutes for Research (AIR) to convene a panel of learning health systems (LHSs) to provide feedback to the AHRQ EPC program in developing and disseminating evidence reports that can be used to improve the quality and effectiveness of patient care. Even if an EPC evidence report topic addresses LHS-specific evidence needs, the density of the information in an evidence report may preclude its easy review by busy LHS leaders and decisionmakers. AHRQ understands that to facilitate use by LHSs, complex evidence reports must be translated into a format that promotes LHS evidence-based decision making and can be contextualized within each LHSs’ own system-generated evidence. Such translational products, for the purposes of this supporting statement, are referred to simply as “products”. The purpose of this information collection is to support a process evaluation of decisionmaking around, and use and implementation of, two such products into LHS decision processes, workflows, and clinical care. The evaluation has the following goals: 1. Document how LHSs prioritize filling evidence gaps, make decisions about using evidence, and implement tools to support and promote evidence use in clinical care. 2. Assess the contextual factors that may influence implementation success; associated implementation resources, barriers and facilitators; and satisfaction of LHS leaders and clinical staff. 3. Provide the AHRQ EPC program with necessary insights about the perspectives, needs, and preferences of LHS leaders and clinical staff as related to decisions and implementation of products into practice.

Authorizing Statute(s): US Code: 42 USC 299 Name of Law: Healthcare Research and Quality Act of 1999

Citations for New Statutory Requirements: None

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	85 FR 6194	02/04/2020
30-day Notice:	Federal Register Citation:	Citation Date:
	85 FR 20497	04/13/2020
Did the Agency receive public comments on this ICR? No

ICR Summary of Burden

	Total Approved	Change Due to Agency Discretion
Annual Number of Responses	308	308
Annual Time Burden (Hours)	216	216
Annual Cost Burden (Dollars)	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: This is a new data collection.

Annual Cost to Federal Government: $230,615

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination. Yes

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination. No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

Agency Contact: Erwin Brown 301 427-1652 erwin.brown@ahrq.hhs.gov

View ICR - OIRA Conclusion